MICROANGIOPATHIC HAEMOLYTIC ANAEMIA

This adverse event was reported 788 times

MICROANGIOPATHIC HAEMOLYTIC ANAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ONASEMNOGENE ABEPARVOVEC-XIOI 9 0.0039
1 SIROLIMUS 37 0.0027
2 PALONOSETRON HYDROCHLORIDE 12 0.0022
3 QUININE 19 0.0022
4 CLINDAMYCIN PHOSPHATE 11 0.0020
5 VANCOMYCIN HYDROCHLORIDE 14 0.0017
6 CARFILZOMIB 39 0.0014
7 ELOTUZUMAB 6 0.0012
8 TACROLIMUS OINTMENT 0.1% 136 0.0011
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 136 0.0011
See all drugs enriched for association with MICROANGIOPATHIC HAEMOLYTIC ANAEMIA